Departamento de Patologia i Terapèutica Experimental, Institut d'Investigació Biomèdica de Bellvitge-Universitat de Barcelona, Laboratori 4145, Campus de Bellvitge, Edifici del Pavelló de Govern, C/Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Endocrinology. 2011 Apr;152(4):1290-9. doi: 10.1210/en.2010-0898. Epub 2011 Feb 1.
Prolonged exposure to high glucose concentration alters the expression of a set of proteins in pancreatic β-cells and impairs their capacity to secrete insulin. The cellular and molecular mechanisms that lie behind this effect are poorly understood. In this study, three either in vitro or in vivo models (cultured rat pancreatic islets incubated in high glucose media, partially pancreatectomized rats, and islets transplanted to streptozotozin-induced diabetic mice) were used to evaluate the dependence of the biological model and the treatment, together with the cell location (insulin granule or plasma membrane) of the affected proteins and the possible effect of sustained insulin secretion, on the glucose-induced changes in protein expression. In all three models, islets exposed to high glucose concentrations showed a reduced expression of secretory granule-associated vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins synaptobrevin/vesicle-associated membrane protein 2 and cellubrevin but minor or no significant changes in the expression of the membrane-associated target-SNARE proteins syntaxin1 and synaptosomal-associated protein-25 and a marked increase in the expression of synaptosomal-associated protein-23 protein. The inhibition of insulin secretion by the L-type voltage-dependent calcium channel nifedipine or the potassium channel activator diazoxide prevented the glucose-induced reduction in islet insulin content but not in vesicle-SNARE proteins, indicating that the granule depletion due to sustained exocytosis was not involved in the changes of protein expression induced by high glucose concentration. Altogether, the results suggest that high glucose has a direct toxic effect on the secretory pathway by decreasing the expression of insulin granule SNARE-associated proteins.
长期暴露于高葡萄糖浓度会改变胰岛β细胞中一组蛋白质的表达,并损害其分泌胰岛素的能力。这种作用的细胞和分子机制尚未完全了解。在这项研究中,使用了三种体外或体内模型(在高葡萄糖培养基中孵育的培养大鼠胰岛、部分胰腺切除术大鼠和移植到链脲佐菌素诱导的糖尿病小鼠中的胰岛)来评估生物模型和治疗的依赖性,以及受影响蛋白质的细胞位置(胰岛素颗粒或质膜)和持续胰岛素分泌的可能影响,对葡萄糖诱导的蛋白质表达变化的影响。在所有三种模型中,暴露于高葡萄糖浓度的胰岛显示出与分泌颗粒相关的囊泡可溶性 N-乙基马来酰亚胺敏感因子附着蛋白受体(SNARE)蛋白突触融合蛋白/囊泡相关膜蛋白 2 和细胞内溶素的表达减少,但膜相关靶-SNARE 蛋白突触素 1 和突触相关蛋白 25 的表达变化较小或无显着变化,突触相关蛋白 23 蛋白的表达明显增加。L 型电压依赖性钙通道硝苯地平或钾通道激活剂二氮嗪对胰岛素分泌的抑制阻止了葡萄糖诱导的胰岛胰岛素含量减少,但不能阻止囊泡-SNARE 蛋白的减少,这表明由于持续胞吐作用导致的颗粒耗竭不参与高葡萄糖浓度诱导的蛋白质表达变化。总的来说,这些结果表明,高葡萄糖通过降低胰岛素颗粒 SNARE 相关蛋白的表达对分泌途径具有直接的毒性作用。